Bellien Jeremy at INSERM U1096 - Research Interests, Publications & Academic Profile

Bellien Jeremy

Professor of Pharmacology, PharmD, PhD

INSERM U1065

France

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Bangladeshi students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cardiology

50%

Pharmacology

20%

Covid-19

20%

Drug Metabolism

20%

Circulatory Physiology

20%

Ischemic Physiology

20%

Atherosclerosis

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats

Article Link

Year:

2023

Subtotal Nephrectomy Associated with a High-Phosphate Diet in Rats Mimics the Development of Calcified Aortic Valve Disease Associated with Chronic Renal Failure

Article Link

Year:

2023

Determination of Lipoxygenase, CYP450, and Non-Enzymatic Metabolites of Arachidonic Acid in Essential Hypertension and Type 2 Diabetes

Article Link

Year:

2022

Soluble RAGE as a Prognostic Marker of Worsening in Patients Admitted to the ICU for COVID-19 Pneumonia: A Prospective Cohort Study

Article Link

Year:

2022

Priming of Cardiopulmonary Bypass with Human Albumin Decreases Endothelial Dysfunction after Pulmonary Ischemia–Reperfusion in an Animal Model

Article Link

Year:

2022

Combined Electron Microscopy Approaches for Arterial Glycocalyx Visualization

Article Link

Year:

2022

Routine and Advanced Laboratory Tests for Hemostasis Disorders in COVID-19 Patients: A Prospective Cohort Study

Article Link

Year:

2022

The effect of camelina oil on vascular function in essential hypertensive patients with metabolic syndrome: a randomized, placebo-controlled, double-blind study

Article Link

Year:

2022

Adaptation of Arterial Wall Viscosity to the Short-Term Reduction of Heart Rate: Impact of Aging

Article Link

Year:

2022

CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury

Article Link

Year:

2022

Collaborators11

Serge Luquet

Université Paris Cité

FRANCE

Duflot Thomas

Associate Professor

INSERM

FRANCE

Carlos Afonso

Professor

University of Rouen

FRANCE

Paul Billoir

Rouen University Hospital

FRANCE

Ahmed Karoui

associate professor

Université Paris-Saclay

FRANCE

Dominique Guerrot

Professor

Université de Rouen Faculté de Médecine et Pharmacie

FRANCE

Youssef Bennis

Université de Picardie Jules Verne

FRANCE

Déborah Groussard

Institut Pasteur

FRANCE

Valéry Brunel

Praticien Hospitalier, Pharm D, Head of Department

FRANCE

Christelle Monteil

University of Rouen

FRANCE

Gilles Rautureau

Professor

Université Claude Bernard Lyon 1 Faculté des Sciences et Technologies

FRANCE

How do Bangladeshi students reach out?

Meet Kite AI